Section Arrow
CDXS.NASDAQ
- Codexis
Quotes are at least 15-min delayed:2025/04/12 22:09 EDT
Last
 2.35
+0.1 (+4.44%)
Day High 
2.37 
Prev. Close
2.25 
1-M High
3.17 
Volume 
722.18K 
Bid
2.22
Ask
2.37
Day Low
2.19 
Open
2.24 
1-M Low
1.9 
Market Cap 
186.38M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.35 
20-SMA 2.57 
50-SMA 3.27 
52-W High 6.08 
52-W Low 1.9 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.89/-0.57
Enterprise Value
243.45M
Balance Sheet
Book Value Per Share
0.81
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
59.35M
Operating Revenue Per Share
0.89
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals5.76+1.25+27.72%-- 
THTXTheratechnologies1.94+0.61+45.86%-- 
CDTConduit Pharmaceuticals Inc0.9101-0.1599-14.94%-- 
PRTGPortage Biotech Inc8.59+3.49+68.43%0.17PE
HEPAHepion Pharmaceuticals0.422-0.0091-2.11%-- 
Quotes are at least 15-min delayed:2025/04/12 22:09 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.